Monterey Private Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$557K Sell
2,659
-132
-5% -$25.7K 0.16% 59
2024
Q4
$496K Buy
2,791
+405
+17% +$74.5K 0.16% 62
2024
Q3
$471K Buy
2,386
+6
+0.3% +$1.12K 0.16% 62
2024
Q2
$408K Buy
2,380
+735
+45% +$122K 0.15% 67
2024
Q1
$300K Sell
1,645
-48
-3% -$8.27K 0.12% 83
2023
Q4
$262K Buy
1,693
+1
+0.1% +$146 0.12% 86
2023
Q3
$252K Buy
1,692
+1
+0.1% +$147 0.13% 84
2023
Q2
$228K Sell
1,691
-1,467
-46% -$215K 0.11% 92
2023
Q1
$503K Buy
3,158
+601
+24% +$91.9K 0.26% 52
2022
Q4
$413K Sell
2,557
-74
-3% -$11.3K 0.22% 55
2022
Q3
$376K Sell
2,631
-144
-5% -$20.7K 0.23% 58
2022
Q2
$425K Buy
2,775
+190
+7% +$29K 0.24% 55
2022
Q1
$423K Buy
2,585
+1
+0% +$145 0.2% 68
2021
Q4
$350K Sell
2,584
-534
-17% -$63.1K 0.17% 76
2021
Q3
$341K Buy
3,118
+1
+0% +$114 0.19% 66
2021
Q2
$351K Buy
3,117
+295
+10% +$33.2K 0.2% 63
2021
Q1
$314K Buy
2,822
+1
+0% +$107 0.17% 66
2020
Q4
$302K Buy
2,821
+1
+0% +$96 0.17% 64
2020
Q3
$247K Buy
2,820
+1
+0% +$94 0.16% 73
2020
Q2
$277K Buy
2,819
+4
+0.1% +$352 0.2% 57
2020
Q1
$214K Sell
2,815
-297
-10% -$25.3K 0.18% 58
2019
Q4
$276K Buy
+3,112
New +$258K 0.22% 59

Other funds holding ABBV

Monterey Private Wealth's ABBV Position: Q1 2025 in Review

Monterey Private Wealth reduced its AbbVie (ABBV) stake by 4.7% in Q1 2025, selling an estimated $25.7K and leaving 2,659 shares worth $557K. The position accounts for 0.16% of the portfolio, ranked #59.

Monterey Private Wealth first reported a position in ABBV in Q4 2019 and has held it in 22 quarters since. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Monterey Private Wealth held 2,659 shares of AbbVie worth $557K as of Q1 2025.
  • Monterey Private Wealth sold 132 AbbVie shares in Q1 2025, an estimated $25.7K.
  • AbbVie made up 0.16% of Monterey Private Wealth's portfolio in Q1 2025, its #59 holding.
  • Monterey Private Wealth first reported a position in AbbVie in Q4 2019 and has held it in 22 quarters since.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Monterey Private Wealth's 13F filing for Q1 2025, filed 14 May 2025.